Omeros Corporation (OMER)

Apr 07, 2025

It makes sense and dollars to buy Omeros Corporation (OMER) stock - Sete News

Apr 07, 2025

Apr 06, 2025

(OMER) Technical Data - news.stocktradersdaily.com

Apr 06, 2025

Apr 05, 2025

FY2025 EPS Estimates for Omeros Reduced by Cantor Fitzgerald - Defense World

Apr 05, 2025

Apr 02, 2025

Omeros (NASDAQ:OMER) Earns "Buy" Rating from D. Boral Capital - MarketBeat

Apr 02, 2025

Apr 02, 2025

Omeros Co. (NASDAQ:OMER) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Apr 02, 2025

Apr 02, 2025

4,671 Shares in Omeros Co. (NASDAQ:OMER) Acquired by Quantbot Technologies LP - Defense World

Apr 02, 2025

Apr 02, 2025

Omeros (NASDAQ:OMER) Receives “Buy” Rating from D. Boral Capital - Defense World

Apr 02, 2025

Apr 02, 2025

Omeros (NASDAQ:OMER) Receives “Hold” Rating from Needham & Company LLC - Defense World

Apr 02, 2025

Apr 02, 2025

Omeros (NASDAQ:OMER) Upgraded to Hold at StockNews.com - Defense World

Apr 02, 2025

Apr 01, 2025

Omeros Corporation’s Earnings Call Highlights Progress and Challenges - TipRanks

Apr 01, 2025

Apr 01, 2025

Omeros Corporation (NASDAQ:OMER) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025

Apr 01, 2025

Omeros (OMER) Exceeds Q4 EPS Expectations, Reports Cash Decline - GuruFocus

Apr 01, 2025

Apr 01, 2025

Omeros: Q4 Earnings Snapshot - CT Insider

Apr 01, 2025

Apr 01, 2025

Omeros Corp (OMER) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with ... - Yahoo Finance

Apr 01, 2025

Apr 01, 2025

Omeros Corp (OMER) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with Strategic Initiatives - GuruFocus

Apr 01, 2025

Mar 31, 2025

Omeros Corporation Reports 2024 Financial Results - TipRanks

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: Omeros Q4 2024 sees narrower EPS loss, stock climbs - Investing.com Canada

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: Omeros Q4 2024 sees narrower EPS loss, stock climbs By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Omeros beats Q4 earnings estimates, shares rise 5% By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Omeros beats Q4 earnings estimates, shares rise 5% - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

OMEROS CORP SEC 10-K Report - TradingView

Mar 31, 2025

Mar 31, 2025

Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results - Yahoo Finance

Mar 31, 2025

Mar 31, 2025

Omeros (OMER) to Release Quarterly Earnings on Monday - Defense World

Mar 31, 2025

Mar 28, 2025

Top Wall Street Forecasters Revamp Omeros Price Expectations Ahead Of Q4 Earnings - Benzinga

Mar 28, 2025

Mar 27, 2025

In the Green: Omeros Corporation (OMER) Closes at 8.52, Up/Down -6.99 from Previous Day - DWinneX

Mar 27, 2025

Mar 27, 2025

Omeros Corporation (OMER) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle

Mar 27, 2025

Mar 27, 2025

Trend Tracker for (OMER) - news.stocktradersdaily.com

Mar 27, 2025

Mar 26, 2025

Strong Buy Rating for Omeros Corporation Driven by Promising Narsoplimab Prospects and Strategic Advancements - TipRanks

Mar 26, 2025

Mar 26, 2025

Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025 - Joplin Globe

Mar 26, 2025

Mar 26, 2025

Omeros Earnings Preview: Key Metrics to Watch in Q4 and Full Year Report - Stock Titan

Mar 26, 2025

Mar 26, 2025

Charles Schwab Investment Management Inc. Decreases Stock Holdings in Omeros Co. (NASDAQ:OMER) - Defense World

Mar 26, 2025

Mar 24, 2025

Bank of New York Mellon Corp Sells 4,919 Shares of Omeros Co. (NASDAQ:OMER) - Defense World

Mar 24, 2025

Mar 24, 2025

Omeros to activate site for Phase III programme of zaltenibart for PNH - Yahoo Finance

Mar 24, 2025

Mar 23, 2025

D. Boral Capital Reaffirms Buy Rating for Omeros (NASDAQ:OMER) - Defense World

Mar 23, 2025

Mar 22, 2025

Omeros (OMER) Expected to Announce Earnings on Monday - Defense World

Mar 22, 2025

Mar 21, 2025

Omeros advances Phase 3 trials for PNH treatment zaltenibart - Investing.com

Mar 21, 2025

Mar 21, 2025

Omeros Says Trial Site Activation Underway for Phase 3 Study of Zaltenibart -March 21, 2025 at 12:53 pm EDT - MarketScreener

Mar 21, 2025

Mar 21, 2025

Omeros advances Phase 3 trials for PNH treatment zaltenibart By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 21, 2025

Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program - The Joplin Globe

Mar 21, 2025

Mar 21, 2025

Omeros' New PNH Drug Could Transform Treatment: 8-Week Dosing vs Current 2-Week Standard - Stock Titan

Mar 21, 2025

Mar 21, 2025

Omeros (NASDAQ:OMER) Downgraded by StockNews.com to Sell - Defense World

Mar 21, 2025

Mar 18, 2025

US Bancorp DE Takes $81,000 Position in Omeros Co. (NASDAQ:OMER) - Defense World

Mar 18, 2025

Mar 17, 2025

Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Mar 17, 2025

Mar 16, 2025

(OMER) On The My Stocks Page - Stock Traders Daily

Mar 16, 2025

Mar 13, 2025

Omeros Corporation Receives Commitment Of Over $4 Million From Nida For Further Development Of The Company'S Oms527 Program To Treat Cocaine Use Disorder - Marketscreener.com

Mar 13, 2025

Mar 13, 2025

Omeros Corporation Receives Commitment of Over $4 Million from NIDA for Further Development of the Company’s OMS527 Program to Treat Cocaine Use Disorder - Business Wire

Mar 13, 2025

Mar 13, 2025

Major Breakthrough: First-Ever Cocaine Addiction Drug Receives $4M NIDA Funding - Stock Titan

Mar 13, 2025

Mar 13, 2025

Omeros (NASDAQ:OMER) Stock Rating Upgraded by StockNews.com - Defense World

Mar 13, 2025

Mar 08, 2025

Omeros Co. (NASDAQ:OMER) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Mar 08, 2025

Mar 07, 2025

Omeros (NASDAQ:OMER) Rating Lowered to Sell at StockNews.com - Defense World

Mar 07, 2025